You are here

  • Home
  • Archive
  • Volume 64, Issue Suppl 1
  • PTH-188 Is it more cost-effective to treat patients with non-dysplastic barrett’s oesophagus with aspirin and statins rather than to undertake endoscopic surveillance?

Alerts

Article menu
Download PDFPDF
Oesophagus, Stomach, Duodenum III
PTH-188 Is it more cost-effective to treat patients with non-dysplastic barrett’s oesophagus with aspirin and statins rather than to undertake endoscopic surveillance?
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address